COVID-19 vaccines: The status and perspectives in delivery points of view
Review
[키워드] ACE2, angiotensin-converting enzyme 2
AD, AAV, adeno-associated virus
Ad, Adenovirus
ADE, Antibody-dependent enhancement
APC, antigen presenting cell
ARDS, acute respiratory distress syndrome
CDC, Centers for Disease Control and Prevention
Coronavirus disease 2019 (COVID-19)
COVID-19, Coronavirus disease 2019
CTLs, cytotoxic T lymphocytes
DC, dendritic cell DC
E protein, envelope protein
EUA, Emergency Use Authorization
FDA, U.S Food and Drug Administration
immune response
LNPs, lipid nanoparticles
M protein, membrane protein
MERS, Middle East respiratory syndrome coronavirus
MSCs, mesenchymal stem cells
N protein, nucleocapsid protein
Neutralizing antibodies
NK cell, natural killer cell
NTD, N-terminal binding domain
PPRs, pattern recognition receptors
RBD, receptor binding domain
RSV, respiratory syncytial virus
S protein, spike protein
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
SARS, severe acute respiratory syndrome coronavirus
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
TMPRSS2, transmembrane protease serine
Toll-like receptor, TLR
Type 1 IFNs, Type 1 interferons
vaccine delivery
WHO, World Health Organization
[DOI] 10.1016/j.addr.2020.12.011 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.addr.2020.12.011 PMC 바로가기 [Article Type] Review